Utah Total Current Liabilities vs Total Assets Analysis
UTMD Stock | USD 67.23 0.06 0.09% |
Utah Medical financial indicator trend analysis is much more than just breaking down Utah Medical Products prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Utah Medical Products is a good investment. Please check the relationship between Utah Medical Total Current Liabilities and its Total Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Total Current Liabilities vs Total Assets
Total Current Liabilities vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Utah Medical Products Total Current Liabilities account and Total Assets. At this time, the significance of the direction appears to have no relationship.
The correlation between Utah Medical's Total Current Liabilities and Total Assets is 0.05. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Assets in the same time period over historical financial statements of Utah Medical Products, assuming nothing else is changed. The correlation between historical values of Utah Medical's Total Current Liabilities and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Utah Medical Products are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Current Liabilities i.e., Utah Medical's Total Current Liabilities and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.05 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Total Current Liabilities
Total Current Liabilities is an item on Utah Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Utah Medical Products are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Assets
Total assets refers to the total amount of Utah Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Utah Medical Products books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Utah Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Utah Medical Products current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, Utah Medical's Enterprise Value Multiple is projected to increase slightly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 30.9M | 32.2M | 24.3M | 20.5M | Total Revenue | 49.1M | 52.3M | 50.2M | 36.6M |
Utah Medical fundamental ratios Correlations
Click cells to compare fundamentals
Utah Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Utah Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 109.8M | 111.7M | 115.6M | 123.9M | 135.5M | 142.2M | |
Other Current Liab | 2.4M | 3.0M | 2.8M | 4.5M | 3.6M | 2.6M | |
Total Current Liabilities | 3.4M | 3.8M | 3.6M | 5.8M | 4.7M | 4.6M | |
Total Stockholder Equity | 101.1M | 102.8M | 107.1M | 114.3M | 128.3M | 134.7M | |
Property Plant And Equipment Net | 10.7M | 11.3M | 11.0M | 10.6M | 10.6M | 9.6M | |
Net Debt | (42.4M) | (51.3M) | (60.6M) | (74.7M) | (92.5M) | (87.9M) | |
Retained Earnings | 110.8M | 111.0M | 115.3M | 126.0M | 138.3M | 145.3M | |
Cash | 42.8M | 51.6M | 61.0M | 75.1M | 92.9M | 97.5M | |
Non Current Assets Total | 54.9M | 49.5M | 42.4M | 34.0M | 29.2M | 27.1M | |
Non Currrent Assets Other | 54.9M | (49.5M) | (2.1M) | (1.5M) | (1.0) | (0.95) | |
Cash And Short Term Investments | 42.8M | 51.6M | 61.0M | 75.1M | 92.9M | 97.5M | |
Net Receivables | 4.7M | 4.1M | 5.1M | 5.5M | 3.4M | 4.5M | |
Common Stock Shares Outstanding | 3.7M | 3.7M | 3.7M | 3.6M | 3.6M | 5.0M | |
Liabilities And Stockholders Equity | 109.8M | 111.7M | 115.6M | 123.9M | 135.5M | 142.2M | |
Non Current Liabilities Total | 5.2M | 5.1M | 4.8M | 3.9M | 2.4M | 2.3M | |
Inventory | 6.9M | 6.2M | 6.6M | 8.8M | 9.6M | 10.1M | |
Other Current Assets | 443K | 346K | 456K | 515K | 428K | 406.6K | |
Other Stockholder Equity | 17K | 115K | 841K | 252K | 594.0K | 564.3K | |
Total Liab | 8.7M | 8.9M | 8.4M | 9.6M | 7.1M | 9.7M | |
Property Plant And Equipment Gross | 10.7M | 11.3M | 33.9M | 33.2M | 34.3M | 36.0M | |
Total Current Assets | 54.9M | 62.3M | 73.2M | 89.9M | 106.3M | 111.6M | |
Accumulated Other Comprehensive Income | (9.8M) | (8.3M) | (9.1M) | (12.0M) | (10.7M) | (10.1M) | |
Intangible Assets | 30.2M | 24.0M | 17.3M | 10.4M | 4.9M | 4.7M | |
Accounts Payable | 1.1M | 788K | 761K | 1.2M | 769K | 1.3M | |
Property Plant Equipment | 10.7M | 11.3M | 11.0M | 10.2M | 11.8M | 10.1M | |
Good Will | 14.0M | 14.2M | 14.1M | 13.4M | 13.7M | 13.0M | |
Other Liab | 4.9M | 4.8M | 4.5M | 3.3M | 3.8M | 4.9M | |
Net Tangible Assets | 56.9M | 64.7M | 75.7M | 90.5M | 104.1M | 62.4M | |
Retained Earnings Total Equity | 110.8M | 111.0M | 115.3M | 126.0M | 144.9M | 93.3M | |
Capital Surpluse | 18K | 115K | 841K | 251K | 225.9K | 214.6K | |
Deferred Long Term Liab | 521K | 651K | 577K | 549K | 494.1K | 356.6K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 1.2 | Earnings Share 4.28 | Revenue Per Share 12.392 | Quarterly Revenue Growth (0.20) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.